NPI: 1376675009 · NEWPORT NEWS, VA 23605 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/09/2007
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/09/2007 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 22,373 | $365K |
| 2019 | 17,232 | $392K |
| 2020 | 15,619 | $447K |
| 2021 | 12,201 | $352K |
| 2022 | 5,356 | $259K |
| 2023 | 5,346 | $387K |
| 2024 | 3,664 | $187K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 28,970 | 2,436 | $2.31M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 21,433 | 1,262 | $31K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 624 | 320 | $23K |
| A4657 | Syringe, with or without needle, each | 5,615 | 1,658 | $23K |
| J1756 | Injection, iron sucrose, 1 mg | 5,850 | 1,463 | $4K |
| J1270 | Injection, doxercalciferol, 1 mcg | 14,465 | 1,335 | $2K |
| 90747 | 14 | 12 | $122.95 | |
| 83970 | 703 | 542 | $50.23 | |
| 90674 | 46 | 38 | $44.28 | |
| 85041 | 754 | 592 | $6.56 | |
| 82728 | 307 | 252 | $6.20 | |
| 83540 | 292 | 240 | $5.16 | |
| 85048 | 725 | 576 | $3.52 | |
| 83550 | 270 | 226 | $3.52 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 1,131 | 146 | $0.17 |
| 82947 | 50 | 43 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 333 | 256 | $0.00 |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 149 | 79 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 60 | 50 | $0.00 |